2-(3,4-dimethylphenyl)-5-phenyl-2,4-dihydropyrazol-3-one | 374924-87-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(3,4-dimethylphenyl)-5-phenyl-2,4-dihydropyrazol-3-one
• 英文别名: 1-(3,4-Dimethylphenyl)-3-phenyl-3-pyrazolin-5-one；2-(3,4-dimethylphenyl)-5-phenyl-2,4-dihydropyrazole-3-one；2-(3,4-dimethylphenyl)-5-phenyl-4H-pyrazol-3-one
• CAS: 374924-87-5
• 化学式: C₁₇H₁₆N₂O
• 分子量: 264.327
• InChiKey: JSCLBWOECQERRY-UHFFFAOYSA-N

物化性质

• 沸点：
  422.1±55.0 °C(Predicted)
• 密度：
  1.14±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  32.7
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(3,4-dimethylphenyl)-5-phenyl-2,4-dihydropyrazol-3-one 在 硫酰氟 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 以100%的产率得到1-(3,4-dimethylphenyl)-3-phenyl-1H-pyrazol-5-yl sulfurofluoridate
  参考文献：
  名称：

  SO 2 F 2介导的吡唑啉酮向吡唑基氟代硫酸盐的转化

  摘要：

  通过吡唑啉酮与SO 2 F 2的反应，以良好至极好的收率，可以实现一类同时具有吡唑和氟硫酸盐官能团的新型N-杂环分子的构建。在Suzuki偶联反应和SuFEx click化学中，氟代硫酸盐部分被用作通用的结构单元。

  DOI：

  10.1039/c9ob00903e
• 作为产物：
  描述：

  苯甲酰乙酸乙酯 、 3,4-二甲基苯肼 在 溶剂黄146 作用下， 反应 24.0h， 以55%的产率得到2-(3,4-dimethylphenyl)-5-phenyl-2,4-dihydropyrazol-3-one
  参考文献：
  名称：

  Hydrazinonaphthalene and Azonaphthalene Thrombopoietin Mimics Are Nonpeptidyl Promoters of Megakaryocytopoiesis

  摘要：

  High-throughput screening for the induction of a luciferase reporter gene in a thrombopoietin (TPO)-responsive cell line resulted in the identification of 4-diazo-3-hydroxy-1-naphthalene-sulfonic acids as TPO mimics. Modification of the core structure and adjustment of unwanted functionality resulted in the development of (5-oxo-1,5-dihydropyrazol-4-ylidene)hydrazines which exhibited efficacies equivalent to those of TPO in several cell-based assays designed to measure thrombopoietic activity. Furthermore, these compounds elicited biochemical responses in TPO-receptor-expressing cells similar to those in TPO itself, including kinase activation and protein phosphorylation. Potencies for the best compounds were high for such low molecular weight compounds (MW < 500) with EC50 values in the region of 1-20 nM.

  DOI：

  10.1021/jm010283l

文献信息

• Thrombopoietin mimetics
  申请人：——

  公开号：US20040019190A1

  公开（公告）日：2004-01-29

  Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy- 1 -azobenzene derivative.

  发明了非肽类TPO类似物。还发明了用于制备目前发明的化合物的新工艺和中间体。还发明了一种治疗血小板减少症的方法，包括给予需要的哺乳动物，包括人类，有效量的选择性羟基-1-偶氮苯衍生物。
• SO₂F₂ mediated transformation of pyrazolones into pyrazolyl fluorosulfates
  作者：Jing Leng、Hua-Li Qin

  DOI：10.1039/c9ob00903e

  日期：——

  The construction of a class of novel N-heterocyclic molecules containing both pyrazole and fluorosulfate functionalities was achieved through the reactions of pyrazolones with SO2F2 in good to excellent yields. The fluorosulfate moieties were utilized as versatile building blocks in the Suzuki coupling reaction and SuFEx click chemistry.

  通过吡唑啉酮与SO 2 F 2的反应，以良好至极好的收率，可以实现一类同时具有吡唑和氟硫酸盐官能团的新型N-杂环分子的构建。在Suzuki偶联反应和SuFEx click化学中，氟代硫酸盐部分被用作通用的结构单元。
• THROMBOPOIETIN MIMETICS
  申请人：Duffy Kevin J.

  公开号：US20130078213A1

  公开（公告）日：2013-03-28

  Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

  本发明涉及非肽类TPO类似物的发明。本发明还涉及用于制备目前发明的化合物的新型过程和中间体。本发明还涉及一种治疗血小板减少症的方法，包括在需要的哺乳动物（包括人类）中给予所选的羟基-1-偶氮苯衍生物的有效量。
• EP1294378A4
  申请人：——

  公开号：EP1294378A4

  公开（公告）日：2004-01-28
• [EN] THROMBOPOIETIN MIMETICS<br/>[FR] MIMIQUES DE THROMBOPOIETINE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2001089457A2

  公开（公告）日：2001-11-29

  Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.